Fate Therapeutics Inc
Officers & Directors
1. Prior to joining Fate, he was the Vice President of Clinical Development at Kite Pharma, a Gilead company. He has also held clinical development positions at Genentech and Amgen.
Sarah Cooley, M.D.: Dr. Cooley has been the Senior Vice President of Research and Development of Fate Therapeutics since 2021. She is also a Professor of Medicine at the University of Minnesota and a member of the Masonic Cancer Center. She has conducted extensive research in the field of natural killer (NK) cell biology and immunotherapy.
Christian Weyer, M.D., M.A.S.: Dr. Weyer has been a Director of Fate Therapeutics since 2014. He is also the President and Chief Medical Officer of ProSciento, a clinical research organization. He has over 25 years of experience in drug development and has held various executive positions at Eli Lilly and Company and Amylin Pharmaceuticals.
Ana Maiques: Ms. Maiques has been a Director of Fate Therapeutics since 2019. She is also the CEO of Neuroelectrics, a medical device company that develops non-invasive brain stimulation technologies. She has received various awards for her entrepreneurial and scientific achievements.
Amir Nashat, Ph.D.: Dr. Nashat has been a Director of Fate Therapeutics since 2016. He is also a Managing Partner at Polaris.,
Fate Therapeutics Inc currently has 161 employees.
|
